Author:
Xia Hui,Strachan Briony C.,Gifford Sean C.,Shevkoplyas Sergey S.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Heal, J. M. & Blumberg, N. Optimizing platelet transfusion therapy. Blood reviews 18, 149–165 (2004).
2. Guidance for Industry: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion. U.S. Food and Drug Administration Guidances
http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm320636.htm
(2012).
3. Paglino, J. C., Pomper, G. J., Fisch, G. S., Champion, M. H. & Snyder, E. L. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 44, 16–24 (2004).
4. Heal, J., Masel, D., Rowe, J. & Blumberg, N. Circulating immune complexes involving the ABO system after platelet transfusion. British journal of haematology 85, 566–572 (1993).
5. Bowden, R. A. et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant [see comments]. Blood 86, 3598–3603 (1995).
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献